SESTD1
SEC14 domain and spectrin repeat-containing protein 1
Also known as: DKFZp434O0515, SESD1_HUMAN, Solo
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86VW0
- Gene
- SESTD1
- Ensembl
- ENSG00000187231
- Chromosome
- 2
- Canonical length
- 696 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Intermediate filaments
OverviewNCBI Gene
Enables phosphatidylinositol-3,4-bisphosphate binding activity and phospholipid binding activity. Involved in negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel. Located in calcium channel complex and intermediate filament cytoskeleton. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
696 residues, UniProt reviewed canonical sequence.
>Q86VW0|SESTD1
1 MEASVILPIL KKKLAFLSGG KDRRSGLILT IPLCLEQTNM DELSVTLDYL LSIPSEKCKA
61 RGFTVIVDGR KSQWNVVKTV VVMLQNVVPA EVSLVCVVKP DEFWDKKVTH FCFWKEKDRL
121 GFEVILVSAN KLTRYIEPCQ LTEDFGGSLT YDHMDWLNKR LVFEKFTKES TSLLDELALI
181 NNGSDKGNQQ EKERSVDLNF LPSVDPETVL QTGHELLSEL QQRRFNGSDG GVSWSPMDDE
241 LLAQPQVMKL LDSLREQYTR YQEVCRQRSK RTQLEEIQQK VMQVVNWLEG PGSEQLRAQW
301 GIGDSIRASQ ALQQKHEEIE SQHSEWFAVY VELNQQIAAL LNAGDEEDLV ELKSLQQQLS
361 DVCYRQASQL EFRQNLLQAA LEFHGVAQDL SQQLDGLLGM LCVDVAPADG ASIQQTLKLL
421 EEKLKSVDVG LQGLREKGQG LLDQISNQAS WAYGKDVTIE NKENVDHIQG VMEDMQLRKQ
481 RCEDMVDVRR LKMLQMVQLF KCEEDAAQAV EWLSELLDAL LKTHIRLGDD AQETKVLLEK
541 HRKFVDVAQS TYDYGRQLLQ ATVVLCQSLR CTSRSSGDTL PRLNRVWKQF TIASEERVHR
601 LEMAIAFHSN AEKILQDCPE EPEAINDEEQ FDEIEAVGKS LLDRLTVPVV YPDGTEQYFG
661 SPSDMASTAE NIRDRMKLVN LKRQQLRHPE MVTTESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SESTD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 15 nTPM
- adipose tissue: 14 nTPM
- spinal cord: 13 nTPM
- breast: 10 nTPM
- salivary gland: 10 nTPM
- urinary bladder: 8.9 nTPM
Single-cell type
- endometrial glandular cells: 950 nCPM
- retinal horizontal cells: 803 nCPM
- endometrial luminal cells: 757 nCPM
- monocytes: 582 nCPM
- adipocytes: 409 nCPM
- salivary acinar cells: 392 nCPM
Immune cell
- non-classical monocyte: 1.6 nTPM
- naive B-cell: 1.5 nTPM
- memory B-cell: 1.2 nTPM
- classical monocyte: 0.9 nTPM
- intermediate monocyte: 0.7 nTPM
- myeloid DC: 0.4 nTPM
Brain region
- white matter: 62 nTPM
- thalamus: 53 nTPM
- basal ganglia: 50 nTPM
- medulla oblongata: 49 nTPM
- spinal cord: 48 nTPM
- midbrain: 43 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.27
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.31
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- phosphatidic acid binding
- phosphatidylinositol-3,4-bisphosphate binding
- phosphatidylinositol-3,5-bisphosphate binding
- phosphatidylinositol-3-phosphate binding
- phosphatidylinositol-4,5-bisphosphate binding
- phosphatidylinositol-4-phosphate binding
- phosphatidylinositol-5-phosphate binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- CRAL-TRIO lipid binding domain
- Divergent CRAL/TRIO domain
- SESTD1-like, spectrin repeats region
- SESTD1-like, spectrin repeat
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SESTD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SESTD1 as an antibody target. Whether an autoantibody or antibody against SESTD1 could matter depends on whether native SESTD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SESTD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SESTD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...